Camurus Ab

Biogram Ab

Beiersdorf Ag

Gs Development Ab

Probi Ab

Fluid-carbon International Ab

Bioactive Polymers Ab

Swedish Oat Fiber Ab

Bioapatite Ab

Bioimplant Ab

Drilletten Ab

Gs Biochem Ab

Kare V Larsson

Bjorn Lindman

Hakan Hakansson

Sven Engstrom

Stig Bengmark

Per-Olof Glantz

Udo Hoppe

Gerhard Sauermann

Ulf S Rothman

Bo T Af Ekenstam

Ake R Lindahl

Julius Curts

Roland Andersson

Tomas Landh

Sven E Bergentz

Magnus Harrod

Bo M Ekman

Per O Glantz

Rolf Attstrom

Carl-Erik Albertsson

Nils Molin

Borje Noren

Bo Krasse

Bjorn Klinge

Goran Odham

Jan Olsson

Bengt L Lindblad

The invention relates to a biodegradable barrier network comprising at least two macromolecular substances, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.

Surface protection of exposed biological tissues

A method for preparing a dispersion of polar lipids in an ethanol-water mixture, the polar lipids including galactolipids. An oil containing polar lipids including galactolipids is diluted using a first ethanol-water mixture having an ethanol concentration close to the critical polarity, wherein upon dilution the polar lipids form a lamellar liquid-crystalline phase, without first forming a hexagonal HII-phase. The invention also refers to an oil obtained by evaporating ethanol and water from the dispersion. The invention further refers to aqueous colloidal dispersions of polar lipids including galactolipids, to an oil containing polar lipids including galactolipids and to pharmaceutical, cosmetic and food compositions including such dispersions and/or oil.

Aqueous dispersion comprising galactolipids and method for production thereof

A method and product for preparing a controlled-release composition are provided. The method comprises formation of a mixture containing at least one amphiphilic substance capable of forming a liquid crystalline phase, in contact with a liquid selected from the group consisting of water, glycerol, ethylene glycol, propylene glycol and mixtures thereof. The method includes a step of providing in such mixture a bioactive material.

Method of preparing controlled-release preparations for biologically

Particles, method of preparing said particles and uses thereof

The invention relates to a controlled-release composition for a biologically active material, wherein said active material has been dissolved or dispersed in an L2-phase comprising

Controlled release composition for a biologically active material

A saliva substitute, the characteristic feature of which is that it comprises water-soluble linseed polysaccharides. Said substitute is preferably in the form of an aqueous solution having a viscosity within the range of 1-30 mPa.s, most preferably 2-10 mPa.s. The substitute can be prepared by extracting the polysaccharides from linseed by means of water or a water solution containing inorganic salts. In addition to the fact that said substitute is useful as a saliva substitute it can also be utilized as a carrier for pharmaceuticals adapted for oral applications.

Saliva substitute

The invention relates to an implant material composition, its preparation, and its use for restoring bone tissue in a human or animal body. The composition comprises a particulate biocompatible bone tissue substitute material distributed in a bioacceptable mixture of (a) a water-based liquid, (b) a monoglyceride, and optionally (c) a triglyceride. The ingredients (a), (b) and (c) form an L2-phase or a lamellary liquid crystalline phase, and are present in such proportions within said phases that they are capable of being transformed into a cubic liquid crystalline phase or a reversed hexagonal liquid crystalline phase when contacted with an aqueous liquid. The phase conversion imparts to the composition such a high viscosity that it functions as an implant material as defined.

Implant material composition, preparation thereof as well as uses

Nutrient composition and method for the preparation thereof

A method and product for preparing a controlled-release composition are provided. The method comprises formation of a mixture containing at least one amphiphilic substance capable of forming a liquid crystalline phase, in contact with a liquid selected from the group consisting of water, glycerol, ethylene glycol, propylene glycol and mixtures thereof. The method includes a step of providing in such mixture a bioactive material. Preferred controlled-release compositions include an alkylbetaine zwitterionic surfactant therein.

An implantable device for supplying liquid to the oral cavity comprises a liquid container having means for keeping the liquid under pressure, a tube, one end of which being connected to the container, said tube consisting of a material which is suitable for subcutaneous location in the human body, and an lead-through bushing connected to the other end of said tube, said bushing consisting of or being coated with a biocompatible material for being implanted into a jaw bone, and comprising a nozzle opening provided with a filter.

Implantable device for the supply of a liquid to the oral cavity

Antithrombogenic article containing lysozyme and heparin adsorbed on a

Micro-capsules

A germicidal composition consists of an aqueous suspension of hydrophilic lipid crystals of 1-monolaurin, and preferably also 1-monomyristin, in a quantity of 20-30 percent by weight, and hydrogen peroxide in a quantity of 0.2-5 percent by weight. The hydrophilic lipid crystals stabilize the hydrogen peroxide, to the effect that the composition retains its germicidal power even after having been stored for a long time. Also, the peroxide disintegrates slowly when the composition has been applied onto skin or mucous membrane.

Germicidal composition

A composition is disclosed which is useful in preventing dental plaque and tartar from forming on the teeth. The composition includes compounds which are esters or their mono or double salts derived from lysine in combination with straight chain or branched, saturated or unsaturated, monovalent aliphatic alcohols having 4 to 20 carbon atoms.

Dental and mouth care preparations

Growing community of inventors

Bjarred, Sweden

Kare V Larsson